Could the Blue Prism share price rise more before a takeover?

With the Blue Prism share price having surged due to a takeover bid, could it go higher still? Our writer considers the outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Robotics specialist Blue Prism (LSE: PRSM) has had a disappointing year, with the shares 12% lower than they were 12 months ago. Over a longer period, the Blue Prism share price has been rewarding for owners, tripling in a little under five years. But recent weakness has flushed out a potential buyer.

Sometimes when companies are approached by a possible suitor, a bidding war ensues and the share price jumps handsomely in just a few months. A recent example was the takeover tussle for Morrisons. But I don’t expect the Blue Prism share price to rise much from its current level despite a takeover bid. Here’s why.

Blue Prism takeover bid

Yesterday, Blue Prism announced to the stock exchange that it had agreed a recommended cash acquisition which valued the company’s shares at £11.25 each. That represents a premium of 35% to the share price before the deal was first mooted last month. However, it’s much lower than before the pandemic. The company entered 2020 with its share price over 50% higher. So for more longstanding shareholders, the deal could mean a substantial loss in their portfolio. It may come across as opportunistic.

On the other hand, the company had been facing difficulties. Some large shareholders reportedly suggested that the company investigate the option of selling itself. The company has been consistently loss-making. While revenue last year grew to £141m, losses were a whopping £82m. So it may be that the company’s business model wasn’t well suited for the stock market. Taking it private may give it breathing space to help it fix its performance issues out of the public glare.

What this means

The bidding process has been in the press for weeks, and a bid has now been agreed by the board. That doesn’t mean that it’s a done deal. It will still need to be approved by shareholders. In the meantime, even in the absence of a white knight bidder at this stage, shareholders who view the bid as opportunistic could try to get the board to elicit a sweetener. For example, they may want the directors to wring a higher offer out of the current bidder.

The share price is actually about 40p higher than the bid price, so clearly some investors reckon that such a deal sweetener could be on the way. So even now, there could be potential upside to the Blue Prism share price.

My next action

But I’m not buying. There’s no guarantee of a higher bid, in which case buying at today’s price, knowing the board has agreed to sell the company for a lower amount, would equate to buying pound coins for £1.04 each — if the deal is finalised.

On top of that, as an investor rather than a speculator, I’m not attracted to the Blue Prism business at this point. Its weak business results highlighted risks ranging from management performance to profitability. Those remain, in my view. Maybe a private equity buyer can fix them. But I wasn’t attracted to the company before the bid and I won’t add it to my portfolio now.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Christopher Ruane has no position in any of the shares mentioned. The Motley Fool UK has recommended Morrisons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »